Charleston, S.C., Market Integration Likely to Drive Physician Groups to Seek Health System A...(this document may betrademarks or regist...),Health
Navigation Links
Charleston, S.C., Market Integration Likely to Drive Physician Groups to Seek Health System Affiliation
Date:11/5/2008
this document may be trademarks or registered trademarks of their respective holders.
'/>"/>
| SOURCE HealthLeaders-InterStudy Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. The Hope Clinic in Charleston, SC invests in technology to prevent vision loss in patients
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
5. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
6. Sodexho, Inc. Announces Patrick E. Connolly as Market President & COO
7. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
9. Paramount Acquisition Corp. Announces Chem Rx Expansion into Albany, New York Market
10. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
11. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Don't I know you? University of Toronto research sheds light on memorial retrieval 2Health News:Docs Not Giving Clear Advice on Infant Sleep Positions 2Health News:Docs Not Giving Clear Advice on Infant Sleep Positions 3Health News:Health Reform is About You and Me, Not One or the Other 2Health News:Health Reform is About You and Me, Not One or the Other 3Health News:West Nile virus infection may persist in kidneys years after initial infection 2Health News:West Nile virus infection may persist in kidneys years after initial infection 3
[0] Nearly 3 Million Doses of H1N1 Vaccine Allocated to Pennsylvania since Start of Vaccination Effort[1] Don't I know you? University of Toronto research sheds light on memorial retrieval[1] Docs Not Giving Clear Advice on Infant Sleep Positions[1] Health Reform is About You and Me, Not One or the Other[0] West Nile virus infection may persist in kidneys years after initial infection
Other Medicine News:Health News:Cell division studies hint at future cancer therapy 2Health News:Cell division studies hint at future cancer therapy 3Health News:Investigating causes of asthma attacks: New sensor system monitors environmental exposure 2Health News:Scientists use nanomaterials to localize and control drug delivery 2Health News:Scientists use nanomaterials to localize and control drug delivery 3Health News:The missing link between belly fat and heart disease? 2Health News:The missing link between belly fat and heart disease? 3Health News:The missing link between belly fat and heart disease? 4Health News:Johns Hopkins to participate in 1000 Genomes Project 2Health News:Super-Thin Drug-Free Coating 'Hides' Stent as It Unblocks Heart Arteries 2Health News:Super-Thin Drug-Free Coating 'Hides' Stent as It Unblocks Heart Arteries 3Health News:Super-Thin Drug-Free Coating 'Hides' Stent as It Unblocks Heart Arteries 4
Cell division studies hint at future cancer therapyInvestigating causes of asthma attacks: New sensor system monitors environmental exposureScientists use nanomaterials to localize and control drug deliveryThe missing link between belly fat and heart disease?Johns Hopkins to participate in 1000 Genomes ProjectSuper-Thin Drug-Free Coating 'Hides' Stent as It Unblocks Heart Arteries
Breaking Medicine Technology:Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults 2Getting Closer to the Origins of Prostate Cancer 56657 1Getting Closer to the Origins of Prostate Cancer 56657 2Getting Closer to the Origins of Prostate Cancer 56657 3Nabors Industries Ltd Third Quarter 2009 Earnings Conference Call Invitation 56654 1Prentice Womens Hospital Launches New Initiative to Better Identify and Address Postpartum Depression 56651 1Prentice Womens Hospital Launches New Initiative to Better Identify and Address Postpartum Depression 56651 2Prentice Womens Hospital Launches New Initiative to Better Identify and Address Postpartum Depression 56651 3Prentice Womens Hospital Launches New Initiative to Better Identify and Address Postpartum Depression 56651 4
[0] Hill-Rom Announces Appointment of James R. Giertz to Board of Directors[0] Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day[1] New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults
Other Medicine Technology:King Pharmaceuticals Announces Plan to Report Positive Data from,Phase III Clinical Trial Evaluating the Combination of Altace with,Hydrochlorothiazide 2Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 2Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 3Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 4Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 5
King Pharmaceuticals Announces Plan to Report Positive Data from,Phase III Clinical Trial Evaluating the Combination of Altace with,HydrochlorothiazideAbraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |